Thyrotoxicosis presenting as choreoathetosis.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use; D001264:Athetosis / Q000209:etiology*; D002819:Chorea / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D009461:Neurologic Manifestations; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000503:physiopathology; D013565:Sympatholytics / Q000627:therapeutic use; D013958:Thyroid Crisis / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D013956:Antithyroid Agents; D013565:Sympatholytics; D012110:Reserpine; D011433:Propranolol; D006145:Guanethidine